MGNet Administrative Core

MGNet 管理核心

• 批准号: 10645044
• 负责人: HENRY J KAMINSKI
• 金额: $ 103.22万
• 依托单位: GEORGE WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-01 至 2024-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10645044
• 关键词: Advertising; Award; Biometry; Clinical; Clinical Research; Clinical Trials; Clinical and Translational Science Awards; Collaborations; Data Analyses; Development; Drug Industry; Education; Financial Support; Foundations; General Hospitals; Goals; Health Professional; Immunologics; Immunologist; Individual; Industry; Information Dissemination; Infrastructure; Institutional Review Boards; International; Investigation; Leadership; Manuscripts; Massachusetts; Mission; Muscular Dystrophies; Myasthenia Gravis; North Carolina; Outcome Measure; Patient Care; Patient advocacy; Patients; Performance; Pharmacologic Substance; Pilot Projects; Preparation; Process; Progress Reports; Rare Diseases; Recording of previous events; Research; Research Project Grants; Resources; Scientist; Services; Site; Strategic Planning; Structure; Therapeutic; Training; Universities; Validation; Virginia; Washington; career; clinical center; clinical trial readiness; data sharing; improved; industry partner; infrastructure development; interest; meetings; member; novel therapeutics; patient advocacy group; payment; predictive marker; process improvement; programs; recruit; success; therapeutic development; translational scientist; web site

The Administrative Core of MGNet serves to support all activities of the RDCRN to optimize clinical research performance and career enhancement activities. We do so by provision of staff focused on facilitation of all activities related to study initiation, performance, and close out activities. Core services for clinical research coordinator training, biostatistical analysis, clinical trial development, and immunological investigations will be provided. The leadership of MGNet includes the administrative coordinator, clinicians, translational scientists, immunologists, patient advocacy group leadership, and patients. This collaborative group will provide oversight and drive process improvement as well as develop a strategic plan to assure the long-term viability of MGNet. Administrative Core will develop focused projects beyond those in the present proposal to enhance clinical trial readiness beyond MGNet sites and partner with industry to optimize the performance of MG clinical trials. The shared goals of all members of MGNet are 1) to provide a structure to enhance discovery and validation of treatment-responsive or – predictive markers with the ultimate goal of enhancing therapeutic development, 2) improve clinical trial outcome measures and infrastructure, and 3) enhance the quality of clinical research for MG. As MGNet matures, the

MGNet的管理核心服务于支持RDCRN的所有活动进行优化